Designing an agentic, future‑ready tech roadmap for emerging pharma

Emerging pharma companies face a unique technology challenge: They must support rapid growth, increasingly complex pipelines, and evolving commercial and medical needs, often with lean teams and constrained budgets. As emerging pharma organizations prepare to launch and scale, early technology decisions play a defining role in how quickly teams can move from insight to action. When designed thoughtfully, choices around data, platforms and operating models can enable an agentic ecosystem—one that adapts, learns and scales alongside the business.

On this podcast, JR Raelin, executive director, analytics and insights, SynOx Therapeutics, and Krishna GS, business technology solutions manager, ZS, will share practical perspectives on how emerging pharma organizations can design an AI‑infused, future‑ready technology roadmap—one that balances today’s execution needs with tomorrow’s scale.

You’ll get practical perspectives on how emerging pharma teams can:

• Approach early platform decisions by focusing on the criteria that matter most—data readiness, flexibility, interoperability and speed to value
• Balance AI and advanced analytics ambition with readiness, ensuring trust, compliance and governance are built in as capabilities evolve
• Drive real adoption through effective implementation and onboarding, especially in the critical first 60-90 days
• Define what success looks like for a future-ready technology roadmap beyond go-live milestones
• Avoid common pitfalls that derail scale, from chasing AI too early to building fragmented systems

The discussion also highlights how platforms like ZAIDYN® help operationalize these principles by embedding trusted intelligence into everyday workflows, enabling better decisions today while building for tomorrow.

This conversation is designed for pharma leaders seeking flexible, scalable technology foundations that evolve with their business.